Medpace Holdings (MEDP) Short term Debt (2015 - 2023)

Medpace Holdings (MEDP) reported Short term Debt of $55.0 million for Q2 2023, down 77.97% on a YoY basis from $249.7 million in Q2 2022, and down 52.17% quarter-over-quarter from $115.0 million in Q1 2023.

Medpace Holdings (MEDP) Short term Debt (2015 - 2023) Analysis & Trends

Medpace Holdings has reported Short term Debt for 6 years, with the latest figure at $55.0 million in Q2 2023.

  • For the quarter ending Q2 2023, Short term Debt fell 77.97% year-over-year to $55.0 million; the trailing twelve-month figure through Jun 2023 stood at $55.0 million (down 77.97% YoY), and the FY2022 full-year result was $50.0 million, changed N/A from the prior year.
  • Short term Debt for Q2 2023 stood at $55.0 million, down from $115.0 million in the prior quarter.
  • The five-year high for Short term Debt was $249.7 million in Q2 2022, with the low at $50.0 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn
10 Medpace Holdings 13.03 Bn 12.38 Bn 196.33 Mn

Historic Data

Download Data
DateValue
Jun 30, 2023 55.00 Mn
Mar 31, 2023 115.00 Mn
Dec 31, 2022 50.00 Mn
Sep 30, 2022 139.70 Mn
Jun 30, 2022 249.70 Mn
Jun 30, 2018 16.50 Mn
Mar 31, 2018 16.50 Mn
Dec 31, 2017 16.50 Mn
Sep 30, 2017 15.47 Mn
Jun 30, 2017 14.44 Mn
Mar 31, 2017 13.41 Mn
Dec 31, 2016 12.38 Mn
Dec 31, 2015 59,000.00